|
|
Volumn 31, Issue 1-2, 1999, Pages 1127-1128
|
|
Mechanisms of cyclosporine-induced nephrotoxicity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
27 O 3 [2 (3 CARBOXYACRYLOYLAMINO) 5 HYDROXYPHENYL]ACRYLOYLOXY MYRICERONE;
BOSENTAN;
CALCIUM;
CYCLOSPORIN A;
ENDOTHELIN A RECEPTOR ANTAGONIST;
ENDOTHELIN B RECEPTOR ANTAGONIST;
ENDOTHELIUM DERIVED RELAXING FACTOR;
NITRIC OXIDE;
PROSTACYCLIN;
RENIN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ARTERY CONSTRICTION;
CONFERENCE PAPER;
CONTROLLED STUDY;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
JUXTAGLOMERULAR CELL;
KIDNEY BLOOD FLOW;
KIDNEY CORTEX;
KIDNEY TUBULE FUNCTION;
MALE;
NEPHROTOXICITY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PATHOGENESIS;
PLASMA RENIN ACTIVITY;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RAT;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RENIN RELEASE;
ADMINISTRATION, ORAL;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
CAFFEIC ACIDS;
CYCLOSPORINE;
INJECTIONS, INTRAVENOUS;
KIDNEY;
KIDNEY CORTEX;
MALE;
OLEANOLIC ACID;
RATS;
RATS, WISTAR;
RECEPTOR, ENDOTHELIN A;
RECEPTORS, ENDOTHELIN;
REGIONAL BLOOD FLOW;
RENAL CIRCULATION;
RENIN;
SULFONAMIDES;
|
|
EID: 0032987465
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01931-9 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (9)
|
